The Wall Street Journal: Pfizer, Glaxo Detail Fees Paid To DoctorsThe Wall Street Journal: Pfizer, Glaxo Disclose Fees To U.S. Doctors
Pfizer Inc. paid $177 million and GlaxoSmithKline PLC paid $85 million during 2010 to U.S. doctors and institutions for their work on clinical trials, consulting, speaking and other items, the companies disclosed Thursday. They were the latest disclosures in a trend toward more transparency by drug makers, which have been criticized for using payments to doctors to unduly influence prescribing patterns, or to promote unauthorized uses of drugs (Loftus, 3/31). This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.